← Leaderboards
Ronald Goldblum
Ancile Pharmaceuticals, Inc.
$504,292
Attributed
$504,292
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$504,292 · 2
By mechanism
R44$292,541 · 1
R43$211,751 · 1
Top collaborators
No co-investigators on record.
Most similar at Ancile Pharmaceuticals, Inc.
Same institution · by research overlap
- Ute Splittgerber$99,970
Others in their field
Top investigators on “Plant Extracts”
- Steven T Dekosky · Rush University Medical Center$18,932,347
- David Heimbrook · Leidos Biomedical Research, Inc.$17,692,058
- Kuo-Hsiung Lee · University Of North Carolina Chapel Hill$13,030,047
- David G Kingston · Virginia Polytechnic Inst And St Univ$10,164,857
- Steven E Reis · University Of Pittsburgh At Pittsburgh$9,329,956
- Shyam Visweswaran · University Of Pittsburgh At Pittsburgh$9,329,956
Research focus
Plant ExtractsHuman SubjectAlternative MedicineClinical Trial Phase IDogsDosageDrug Design /Synthesis /ProductionLaboratory RatMethod DevelopmentPatient Oriented ResearchPharmacokineticsPhobiasSleep DisordersSocial BehaviorAnxiety DisordersClinical Research